Diabetes
55:318-325,
2006
DOI: 10.2337/diabetes.55.02.06.db05-0757
© 2006 by the American Diabetes Association
Akt Induces ß-Cell Proliferation by Regulating Cyclin D1, Cyclin D2, and p21 Levels and Cyclin-Dependent Kinase-4 Activity
Szabolcs Fatrai1,
Lynda Elghazi1,
Norman Balcazar1,
Corentin Cras-Méneur1,
Irina Krits1,
Hiroaki Kiyokawa2, and
Ernesto Bernal-Mizrachi1
1 Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, Missouri
2 Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois, Chicago, Illinois
Address correspondence and reprint requests to Ernesto Bernal-Mizrachi, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8127, St. Louis, MO 63110. E-mail: ebernal{at}wustl.edu
Key Words: BrdU, bromodeoxyuridine cdk4, cyclin-dependent kinase-4 FOXO1, forkhead box factor 1 GSK, glycogen synthase kinase INK4, inhibitor of cdk4 PI 3-kinase, phosphoinositide 3-kinase
Proliferation is the major component for maintenance of ß-cell mass in adult animals. Activation of phosphoinositide 3-kinase/Akt-kinase pathway is a critical regulator of ß-cell mass. Pancreatic ß-cell overexpression of constitutively active Akt in mice (caAktTg) resulted in marked expansion of ß-cell mass by increase in ß-cell proliferation and size. The current studies provide new insights into the molecular mechanisms involved in ß-cell proliferation by Akt. Proliferation of ß-cells in caAktTg was associated with increased cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 (cdk4) activity. To determine the role of cdk4 in ß-cell proliferation induced by Akt, we generated caAktTg mice that were homozygous, heterozygous, or nullizygous for cdk4. The results of these studies showed that deletion of one cdk4 allele significantly reduced ß-cell expansion in caAktTg mice by decreased proliferation. CaAktTg mice deficient in cdk4 developed ß-cell failure and diabetes. These experiments suggest that Akt induces ß-cell proliferation in a cdk4-dependent manner by regulation of cyclin D1, cyclin D2, and p21 levels. These data also indicate that alteration in levels of these cell cycle components could affect the maintenance of ß-cell mass in basal states and the adaptation of ß-cells to pathological states resulting in diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Kato, H. Shimano, T. Yamamoto, M. Ishikawa, S. Kumadaki, T. Matsuzaka, Y. Nakagawa, N. Yahagi, M. Nakakuki, A. H. Hasty, et al.
Palmitate Impairs and Eicosapentaenoate Restores Insulin Secretion Through Regulation of SREBP-1c in Pancreatic Islets
Diabetes,
September 1, 2008;
57(9):
2382 - 2392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fulzele, D. J. DiGirolamo, Z. Liu, J. Xu, J. L. Messina, and T. L. Clemens
Disruption of the Insulin-like Growth Factor Type 1 Receptor in Osteoblasts Enhances Insulin Signaling and Action
J. Biol. Chem.,
August 31, 2007;
282(35):
25649 - 25658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Alonso, T. Yokoe, P. Zhang, D. K. Scott, S. K. Kim, C. P. O'Donnell, and A. Garcia-Ocana
Glucose Infusion in Mice: A New Model to Induce {beta}-Cell Replication
Diabetes,
July 1, 2007;
56(7):
1792 - 1801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mussmann, M. Geese, F. Harder, S. Kegel, U. Andag, A. Lomow, U. Burk, D. Onichtchouk, C. Dohrmann, and M. Austen
Inhibition of GSK3 Promotes Replication and Survival of Pancreatic Beta Cells
J. Biol. Chem.,
April 20, 2007;
282(16):
12030 - 12037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M Ackermann and M. Gannon
Molecular regulation of pancreatic {beta}-cell mass development, maintenance, and expansion
J. Mol. Endocrinol.,
February 1, 2007;
38(2):
193 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Vasavada, I. Cozar-Castellano, D. Sipula, and A. F. Stewart
Tissue-Specific Deletion of the Retinoblastoma Protein in the Pancreatic {beta}-Cell Has Limited Effects on {beta}-Cell Replication, Mass, and Function
Diabetes,
January 1, 2007;
56(1):
57 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Cozar-Castellano, M. Haught, and A. F. Stewart
The Cell Cycle Inhibitory Protein p21cip Is Not Essential for Maintaining {beta}-Cell Cycle Arrest or {beta}-Cell Function In Vivo
Diabetes,
December 1, 2006;
55(12):
3271 - 3278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Peshavaria, B. L. Larmie, J. Lausier, B. Satish, A. Habibovic, V. Roskens, K. LaRock, B. Everill, J. L. Leahy, and T. L. Jetton
Regulation of Pancreatic {beta}-Cell Regeneration in the Normoglycemic 60% Partial-Pancreatectomy Mouse
Diabetes,
December 1, 2006;
55(12):
3289 - 3298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Cozar-Castellano, N. Fiaschi-Taesch, T. A. Bigatel, K. K. Takane, A. Garcia-Ocana, R. Vasavada, and A. F. Stewart
Molecular Control of Cell Cycle Progression in the Pancreatic {beta}-Cell
Endocr. Rev.,
June 1, 2006;
27(4):
356 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Diabetes Association.
|
|
| |
|